Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: Correlates of use, abuse and dependence

Drug and Alcohol Dependence

Volumn 99, Issue 1-3, 2009, Pages 338-344

  Lavie, Estelle ^a,b   Fatséas, Mélina ^a,b   Denis, Cécile ^a,b   Auriacombe, Marc ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CENTRE HOSPITALIER CHARLES PERRENS   (France)

Author keywords

Abuse; Benzodiazepines; Buprenorphine; Dependence; Problematic use

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CANNABIS; COCAINE; FLUNITRAZEPAM; OPIATE; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; CANNABIS ADDICTION; COCAINE DEPENDENCE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FRANCE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NOTTINGHAM HEALTH PROFILE; OPIATE ADDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BENZODIAZEPINES; BUPRENORPHINE; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HUMANS; MALE; NARCOTICS; OPIOID-RELATED DISORDERS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; SEX FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 57049139312     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.07.017     Document Type: Article

References (33)

1. Auriacombe M., Fatseas M., Dubernet J., Daulouede J.P., and Tignol J. French field experience with buprenorphine. Am. J. Addict. 1 13 Suppl. (2004) S17-S28
2. Auriacombe M., Franques P., Gauchon I., Daulouede J.P., and Tignol J. Impact on mortality of the introduction substitution treatment for heroin dependent users: a naturalistic quasi-randomized outcome study. Drug Alcohol Depend. 63 (2001) S9
3. Backmund M., Meyer K., Henkel C., Soyka M., Reimer J., and Schutz C.G. Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients. J. Addict. Dis. 24 (2005) 17-29
4. Barnas C., Rossmann M., Roessler H., Riemer Y., and Fleischhacker W.W. Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference. J. Clin. Psychopharmacol. 12 (1992) 397-402
5. Beck A.T., Epstein N., Brown G., and Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. J. Consult. Clin. Psychol 56 (1988) 893-897
6. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 561-571
7. Bleich A., Gelkopf M., Schmidt V., Hayward R., Bodner G., and Adelson M. Correlates of benzodiazepine abuse in methadone maintenance treatment. A 1-year prospective study in an Israeli clinic. Addiction 94 (1999) 1533-1540
8. Bleich A., Gelkopf M., Weizman T., and Adelson M. Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach. Isr. J. Psychiatry Relat. Sci. 39 (2002) 104-112
9. Bramness J.G., and Kornor H. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway. Drug Alcohol Depend. (2007)
10. Bucquet D., Condon S., and Ritchie K. The French version of the Nottingham Health Profile. A comparison of items weights with those of the source version. Soc. Sci. Med. 30 (1990) 829-835
11. Busto U., Sellers E.M., Naranjo C.A., Cappell H.D., Sanchez-Craig M., and Simpkins J. Patterns of benzodiazepine abuse and dependence. Br. J. Addict. 81 (1986) 87-94
12. Center for Substance Abuse Treatment. Clinical Guidelines for the use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (2004), Substance Abuse and Mental Health Services Administration, Rockville (MD) p. 171
13. Darke S., Swift W., Hall W., and Ross M. Drug use, HIV risk-taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug Alcohol Depend. 34 (1993) 67-70
14. Fatseas M., and Auriacombe M. Why buprenorphine is so successful in treating opiate addiction in France. Curr. Psychiatry Rep. 9 (2007) 358-364
15. French Monitoring Centre for Drugs and Drug Addiction. Opiate substitution treatment in France: recent results 2004. OFDT Tendances 37 (2004) 8
16. Gelkopf M., Bleich A., Hayward R., Bodner G., and Adelson M. Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic. Drug Alcohol Depend. 55 (1999) 63-68
17. Giacomuzzi S.M., Ertl M., Kemmler G., Riemer Y., and Vigl A. Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment. Sci. World J. 5 (2005) 452-468
18. Hunt S.M., and McEwen J. The development of a subjective health indicator. Sociol. Health Illn. 2 (1980) 231-246
19. Iguchi M.Y., Handelsman L., Bickel W.K., and Griffiths R.R. Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend. 32 (1993) 257-266
20. Kakko J., Svanborg K.D., Kreek M.J., and Heilig M. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet 361 (2003) 662-668
21. Lecrubier Y., Sheehan D., Weiller E., Amorim P., Bonora L., Harnett Sheehan K., Janavs J., and Dunbar G. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur. Psychiatry 12 (1997) 224-231
22. Mattick R.P., Kimber J., Breen C., and Davoli M. Buprenorphine Maintenance Versus Placebo or Methadone Maintenance for Opioid Dependence (Cochrane Review) (2003), The Cochrane Library
23. Miller N.S., and Gold M.S. Abuse, addiction, tolerance, and dependence to benzodiazepines in medical and nonmedical populations. Am. J. Drug Alcohol Abuse 17 (1991) 27-37
24. Morel A. Traitements de substitution à la buprénorphine: l'expérience française. Toxibase 3 (2000) 1-37
25. Nielsen S., Dietze P., Lee N., Dunlop A., and Taylor D. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment. Addiction (2007)
26. Perera K.M.H., Tulley M., and Jenner F.A. The use of benzodiazepines among drug addicts. Br. J. Addict. 82 (1987) 511-516
27. Posternak M.A., and Mueller T.I. Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence. Am. J. Addict. 10 (2001) 48-68
28. Ross J., and Darke S. The nature of benzodiazepine dependence among heroin users in Sydney, Australia. Addiction 95 (2000) 1785-1793
29. Rutherford M.J., Cacciola J.S., Alterman A.I., McKay J.R., and Cook T.G. Contrasts between admitters and deniers of drug use. J Subst. Abuse Treat. 18 (2000) 343-348
30. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., and Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59 Suppl 20 (1998) 22-33 quiz 34-57
31. Stitzer M.L., Griffiths R.R., McLellan A.T., Grabowski J., and Hawthorne J.W. Diazepam use among methadone maintenance patients: patterns and dosages. Drug Alcohol Depend. 8 (1981) 189-199
32. Thirion X., Lapierre V., Micallef J., Ronfle E., Masut A., Pradel V., Coudert C., Mabriez J.C., and Sanmarco J.L. Buprenorphine prescription by general practitioners in a French region. Drug Alcohol Depend. 65 (2002) 197-204
33. Thirion X., Micallef J., Barrau K., Djezzar S., Lambert H., Sanmarco J.L., and Lagier G. Recent evolution in opiate dependence in France during generalisation of maintenance treatments. Drug Alcohol Depend. 61 (2001) 281-285